Compounds > 5-carbamoyl-1h-imidazol-4-yl-piperonylate
Page last updated: 2024-09-03

5-carbamoyl-1h-imidazol-4-yl-piperonylate and 4-carbamoylimidazolium 5-olate

5-carbamoyl-1h-imidazol-4-yl-piperonylate has been researched along with 4-carbamoylimidazolium 5-olate in 3 studies

Compound Research Comparison

Studies
(5-carbamoyl-1h-imidazol-4-yl-piperonylate)		Trials
(5-carbamoyl-1h-imidazol-4-yl-piperonylate)		Recent Studies (post-2010)
(5-carbamoyl-1h-imidazol-4-yl-piperonylate)		Studies
(4-carbamoylimidazolium 5-olate)		Trials
(4-carbamoylimidazolium 5-olate)		Recent Studies (post-2010) (4-carbamoylimidazolium 5-olate)
5001230

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukui, M; Inaba, M; Sakurai, Y; Tsukagoshi, S2
Fukui, M; Inaba, M; Sakurai, Y; Tsukagoshi, S; Yoshida, N1

Other Studies

3 other study(ies) available for 5-carbamoyl-1h-imidazol-4-yl-piperonylate and 4-carbamoylimidazolium 5-olate

ArticleYear
Selective reduction of intracellular guanosine 5'-triphosphate pool by 4-carbamoylimidazolium 5-olate in murine tumor cells.
    Cancer research, 1986, Volume: 46, Issue:1

    Topics: Adenine Phosphoribosyltransferase; Animals; Carcinoma, Ehrlich Tumor; Cell Line; Drug Resistance; Guanosine Triphosphate; Imidazoles; IMP Dehydrogenase; Leukemia P388; Mice; Neoplasms, Experimental

1986
New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
    Cancer research, 1982, Volume: 42, Issue:3

    Topics: Adenine Phosphoribosyltransferase; Animals; Antineoplastic Agents; Cells, Cultured; Chromatography, Thin Layer; Enzyme Activation; Imidazoles; IMP Dehydrogenase; Inosine Nucleotides; Leukemia L5178; Leukemia, Experimental; Mice; Pentosyltransferases; Purines

1982
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
    Cancer research, 1982, Volume: 42, Issue:3

    Topics: Animals; Antineoplastic Agents; Biotransformation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanosine Monophosphate; Hypoxanthine Phosphoribosyltransferase; Imidazoles; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mercaptopurine; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Purines

1982